Diagnosis and Management: Trichomoniasis

Main Article Content

Wanida Rodrangnok
Chenchit Chayachinda
Rossaphorn Kittiyaowamarn


Trichomoniasis, one of the common sexually transmitted diseases, can be asymptomatic or causes severe life disturbance. Although plain antibiotics like metronidazole can cure trichomoniasis, its persistence seems to be endless. The main obstacle against its elimination is diagnosis and management. This article aims to review the disease, especially on diagnosis and management and raise awareness among medical personnel.


Download data is not yet available.

Article Details

How to Cite
Rodrangnok W, Chayachinda C, Kittiyaowamarn R. Diagnosis and Management: Trichomoniasis . Siriraj Med Bull [Internet]. 2021 Jan. 4 [cited 2023 Dec. 3];14(1):64-9. Available from: https://he02.tci-thaijo.org/index.php/simedbull/article/view/245530
Review Article


1. Bouchemal K, Bories C, Loiseau PM. Strategies for Prevention and Treatment of Trichomonas vaginalis Infections. Clin Microbiol Rev. 2017;30(3):811-25.
2. Lazenby GB, Soper DE, Nolte FS. Correlation of leukorrhea and Trichomonas vaginalis infection. J Clin Microbiol. 2013;51(7):2323-7.
3. Hobbs MM, Sena AC. Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect. 2013;89(6):434-8.
4. Gupta S, editor. Sexually transmitted infections. 2nded. Haryama : Elsevier; 2012.
5. รสพร กิตติเยาวมาลย์. พยาธิช่องคลอด. ใน: นิสิต คงเกริกเกียรติ, รสพร กิตติเยาวมาลย์, เอกชัย แดงสอาด, บรรณาธิการ. แนวทางการดูแลรักษาโรคติดต่อทางเพศสัมพันธ์ พ.ศ.2558. พิมพ์ครั้งที่ 2. กรุงเทพฯ: อักษรกราฟฟิคแอนด์ดีไซน์; 2560. หน้า 41-3
6. Workowski KA, Bolan GA, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.
7. Bosserman EA, Helms DJ, Mosure DJ, Secor WE, Workowski KA. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis. 2011;38(10):983-
8. Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006;50(12):4209-10.
9. McClean H, Radcliffe K, Sullivan A, Ahmed-Jushuf I. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013;24(4):253-61.
10. Chayachinda C, Kerdklinhom C, Tachawatcharapunya S, Saisaveoy N. Video-based education versus nurse-led education for partner notification in Thai women with sexually transmitted infections: a randomized controlled trial. Int J STD AIDS. 2018;29(11):1076-83.
11. Anderson BL, Firnhaber C, Liu T, Swarts A, Siminya M, Ingersoll J, et al. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis. 2012;39(8):638-42.
12. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36(1):11-6.
13. Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA. Int J STD AIDS. 2013;24(2):123-7.
14. Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, et al. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010;55(5):565-71.
15. Kissinger P, Adamski A. Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013;89(6):426-33.
16. Balkus JE, Richardson BA, Mochache V, Chohan V, Chan JD, Masese L, et al. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis. 2013;40(6):499-505.
17. Cotch MF, Pastorek JG, 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24(6):353-60.
18. Gumbo FZ, Duri K, Kandawasvika GQ, Kurewa NE, Mapingure MP, Munjoma MW, et al. Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting. J Perinatol. 2010;30(11):717-23.
19. Crosby RA, Charnigo RA, Weathers C, Caliendo AM, Shrier LA. Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect. 2012;88(7):484-9.
20. Garcia PJ, Holmes KK, Carcamo CP, Garnett GP, Hughes JP, Campos PE, et al. Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet. 2012;379(9821):1120-8.
21. Balkus JE, Richardson BA, Mandaliya K, Kiarie J, Jaoko W, Ndinya-Achola JO, et al. Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections. J Infect Dis. 2011;204(2):323-6.
22. Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect. 2009;85(2):116-20.